Umb Bank, N.A. Charles River Laboratories International, Inc. Transaction History

Umb Bank, N.A.

$5.92 Billion
Q1 2025

A detailed history of Umb Bank, N.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 176 shares of CRL stock, worth $18,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares

176

Previous 269 34.57%

Holding current value

$18,761

Previous $49,000 46.94%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	SELL	$150.52 - $190.14 $13,998 - $17,683	-93 Reduced 34.57%	176 $26,000
Q4 2024 Jan 16, 2025	SELL	$178.58 - $220.69 $18,572 - $22,951	-104 Reduced 27.88%	269 $49,000
Q3 2024 Oct 08, 2024	SELL	$187.96 - $245.29 $187 - $245	-1 Reduced 0.27%	373 $73,000
Q2 2024 Jul 29, 2024	SELL	$206.39 - $268.73 $5,366 - $6,986	-26 Reduced 6.5%	374 $77,000
Q1 2024 Apr 26, 2024	BUY	$203.52 - $273.43 $407 - $546	2 Added 0.5%	400 $108,000
Q4 2023 Jan 23, 2024	SELL	$164.52 - $238.84 $28,297 - $41,080	-172 Reduced 30.18%	398 $94,000
Q2 2023 Jul 25, 2023	SELL	$183.71 - $210.25 $9,185 - $10,512	-50 Reduced 8.06%	570 $119,000
Q1 2023 Apr 11, 2023	SELL	$191.89 - $259.92 $383 - $519	-2 Reduced 0.32%	620 $125,000
Q4 2022 Jan 10, 2023	BUY	$197.11 - $250.07 $394 - $500	2 Added 0.32%	622 $135,000
Q3 2022 Oct 13, 2022	BUY	$182.44 - $250.54 $48,711 - $66,894	267 Added 75.64%	620 $122,000
Q2 2022 Jul 20, 2022	BUY	$204.13 - $302.4 $6,940 - $10,281	34 Added 10.66%	353 $76,000
Q4 2021 Feb 09, 2022	BUY	$351.38 - $448.68 $112,090 - $143,128	319 New	319 $121,000

Others Institutions Holding CRL

# of Institutions

704

Shares Held

50.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $5.42B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account